Use of Synvisc® in Knee Osteoarthritis - Survey on Practice

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Hyaluronic Acid; Hylan

Criteria

Inclusion Criteria:

• not applicable

Exclusion Criteria:

• none